Intra-arterial transplantation of stem cells in large animals as a minimally-invasive strategy for the treatment of disseminated neurodegeneration
Author
Malysz-Cymborska, I.Golubczyk, D.
Kalkowski, L.
Kwiatkowska, J.
Zawadzki, M.
Głodek, J.
Holak, P.
Sanford, J.
Milewska, K.
Adamiak, Z.
Walczak, P.
Janowski, M.
Date
2021-03-22Journal
Scientific ReportsPublisher
Nature ResearchType
Article
Metadata
Show full item recordAbstract
Stem cell transplantation proved promising in animal models of neurological diseases; however, in conditions with disseminated pathology such as ALS, delivery of cells and their broad distribution is challenging. To address this problem, we explored intra-arterial (IA) delivery route, of stem cells. The goal of this study was to investigate the feasibility and safety of MRI-guided transplantation of glial restricted precursors (GRPs) and mesenchymal stem cells (MSCs) in dogs suffering from ALS-like disease, degenerative myelopathy (DM). Canine GRP transplantation in dogs resulted in rather poor retention in the brain, so MSCs were used in subsequent experiments. To evaluate the safety of MSC intraarterial transplantation, naïve pigs (n = 3) were used as a pre-treatment control before transplantation in dogs. Cells were labeled with iron oxide nanoparticles. For IA transplantation a 1.2-French microcatheter was advanced into the middle cerebral artery under roadmap guidance. Then, the cells were transplanted under real-time MRI with the acquisition of dynamic T2*-weighted images. The procedure in pigs has proven to be safe and histopathology has demonstrated the successful and predictable placement of transplanted porcine MSCs. Transplantation of canine MSCs in DM dogs resulted in their accumulation in the brain. Interventional and follow-up MRI proved the procedure was feasible and safe. Analysis of gene expression after transplantation revealed a reduction of inflammatory factors, which may indicate a promising therapeutic strategy in the treatment of neurodegenerative diseases. Copyright 2021, The Author(s).Keyword
intra-arterial transplantationMesenchymal Stem Cell Transplantation--methods
Models, Animal
Neurodegenerative Diseases
Identifier to cite or link to this item
http://hdl.handle.net/10713/15173ae974a485f413a2113503eed53cd6c53
10.1038/s41598-021-85820-3
Scopus Count
Collections
Related articles
- In vivo MR imaging of intraarterially delivered magnetically labeled mesenchymal stem cells in a canine stroke model.
- Authors: Lu SS, Liu S, Zu QQ, Xu XQ, Yu J, Wang JW, Zhang Y, Shi HB
- Issue date: 2013
- Mesenchymal stem cells injected into carotid artery to target focal brain injury home to perivascular space.
- Authors: Andrzejewska A, Dabrowska S, Nowak B, Walczak P, Lukomska B, Janowski M
- Issue date: 2020
- Intrathecal Transplantation of Autologous and Allogeneic Bone Marrow-Derived Mesenchymal Stem Cells in Dogs.
- Authors: Benavides FP, Pinto GBA, Heckler MCT, Hurtado DMR, Teixeira LR, Monobe MMS, Machado GF, de Melo GD, Rodríguez-Sánchez DN, Alvarenga FDCLE, Amorim RM
- Issue date: 2021 Jan-Dec
- Adult autologous mesenchymal stem cells for the treatment of suspected non-infectious inflammatory diseases of the canine central nervous system: safety, feasibility and preliminary clinical findings.
- Authors: Zeira O, Asiag N, Aralla M, Ghezzi E, Pettinari L, Martinelli L, Zahirpour D, Dumas MP, Lupi D, Scaccia S, Konar M, Cantile C
- Issue date: 2015 Sep 29
- In vivo magnetic resonance imaging of iron oxide-labeled, intravenous-injected mesenchymal stem cells in kidneys of rabbits with acute ischemic kidney injury: detection and monitoring at 1.5 T.
- Authors: Zhang R, Li J, Xin L, Xie J
- Issue date: 2015